StockNasdaqGSBIIB
Biogen
$248.35
+7.47 (+3.10%)today
Valuation & earnings
- P/E ratio
- 107.51
- Forward P/E
- 15.27
- EPS (ttm)
- $2.31
- Forward EPS
- $16.26
- Price/book
- 1.94
- PEG ratio
- 3.38
- Dividend yield
- 0%
- Payout ratio
- 0%
Financials (ttm)
- Revenue (ttm)
- 10.3B
- Revenue growth
- 10.6%
- Profit margin
- 3.38%
- Return on equity
- 1.87%
- Total cash
- 1.3B
- Total debt
- 7.8B
Earnings (EPS)
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| Dec 31, 2025 | 1.62 | 1.99 | +23.18% |
| Mar 31, 2026 | 2.95 | 3.57 | +20.93% |
| Jun 30, 2026 | 2.03 | 3.6 | +77.38% |
| Sep 30, 2026 | 1.99 | 2.62 | +31.53% |
Next earnings date: Oct 28, 2026
Analyst view
Consensus ratingBuy36 analysts
Strong buy 4Buy 21Hold 10Sell 1
12-month price targetsImplied upside: +7.26%
175
266.39
350
LowCurrent priceHigh
Related products
How visible is Biogen in AI search?
We ask AI search engines about Biogen and its market — live — and measure whether and how prominently the brand appears in their answers.
No AI visibility check has been run for Biogen yet.
Run a live check to see how AI search engines talk about this brand right now.
Is your brand this visible in AI search?
Aurora tracks your brand across 7 AI search engines — visibility, share of voice and the sources that shape AI answers.